DOROTHY MURPHY: Open Payments
NPI 1922098821 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $165 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 9 | $148 |
| ABBVIE INC. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $39 |
| Organon LLC | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: ZURZUVAE, LILETTA, Veozah, Mirena, NEXPLANON, APTIMA, MOUNJARO, MYFEMBREE.
Industry payments across DC — which companies pay providers there.
